Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

523.88
Delayed Data
As of Jun 16
 -3.91 / -0.74%
Today’s Change
441.00
Today|||52-Week Range
664.64
+8.44%
Year-to-Date

Stock Price Forecast

The 20 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 628.50, with a high estimate of 814.00 and a low estimate of 460.00. The median estimate represents a +19.97% increase from the last price of 523.88.

Analyst Recommendations

The current consensus among 23 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$18.57
Sales
$4.1B
Reporting Date
Aug 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 87.77%
 
 
 
 
 
 
Growthannually 55.86%
 
 
 
 
 
 

Sales

Growthquarterly 60.78%
 
 
 
 
 
 
Growthannually 43.88%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.